Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

NCT00522548 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
37
Enrollment
OTHER
Sponsor class

Stopped enrollment halted in order to have all patients complete follow-up by Jan 2011

Conditions

Interventions

Sponsor

University of Pennsylvania

Collaborators